METASTATIC RENAL CELL CARCINOMA WITH CLEAR-CELL COMPONENT
Clinical trials for METASTATIC RENAL CELL CARCINOMA WITH CLEAR-CELL COMPONENT explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA WITH CLEAR-CELL COMPONENT trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA WITH CLEAR-CELL COMPONENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo takes on kidney cancer in major trial
Disease control CompletedThis Phase 3 trial tested whether combining pembrolizumab (an immunotherapy) with epacadostat (a drug that boosts the immune response) works better than standard drugs (sunitinib or pazopanib) for people with advanced kidney cancer that hasn't been treated before. The study enrol…
Matched conditions: METASTATIC RENAL CELL CARCINOMA WITH CLEAR-CELL COMPONENT
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for kidney cancer patients after immunotherapy fails
Disease control CompletedThis study looked at whether the drug cabozantinib can help people with advanced kidney cancer that got worse after initial treatment with immunotherapy. 127 participants received cabozantinib as a second-line therapy. The main goal was to see how many patients experienced tumor …
Matched conditions: METASTATIC RENAL CELL CARCINOMA WITH CLEAR-CELL COMPONENT
Phase: PHASE2 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC